
• and
New
Top
Community


5
Share this post

BioByte 056: the first approved CRISPR medicine, LLMs for genetic discovery, generative models for protein complexes, super-additivity in combination therapies, new NVIDIA-Genentech collaboration
www.decodingbio.com

14
Share this post

Scaling Biology: Chris Gibson, Co-Founder and CEO of Recursion Pharmaceuticals
www.decodingbio.com

3
Share this post

BioByte 55: a new chemistry foundation model, deep learning for affinity prediction, gliomas hijack neuronal processes, standardized single-cell data sets, Novartis calls on a Legend
www.decodingbio.com

10
Share this post

BioByte 54: reprogramming therapies with mRNA, building bioweapons with chatbots, using active learning to traverse the chemical space, and more
www.decodingbio.com

10
Share this post

BioByte 53: A new AlphaFold model, Future House to accelerate science, the shallow brain hypothesis, direct conversion of carbon to nitrogen, Lilly likes cardiovascular disease
www.decodingbio.com

7
Share this post

BioByte 052: supercomputers and comp bio, foundation models for genes and cells, neural scaling of deep chemical models, ML-driven T cell infiltration prediction for solid tumors
www.decodingbio.com

Decoding Bio
your guide to the latest in tech x bio
Recommendations
Elliot Hershberg
Patrick Malone
Niko McCarty
Share this publication

Decoding Bio
www.decodingbio.com
By registering you agree to Substack's Terms of Service, our Privacy Policy, and our Information Collection Notice
© 2023 Decoding Bio
Substack is the home for great writing